Roche Holding AG (SWX:ROG)
Switzerland · Delayed Price · Currency is CHF 275.60
+6.10 (2.26%)
Sep 4, 2025, 2:04 PM CET
Roche Holding AG Employees
Roche Holding AG had 103,249 employees as of December 31, 2024. The number of employees decreased by 356 or -0.34% compared to the previous year.
Employees
103,249
Change (1Y)
-356
Growth (1Y)
-0.34%
Revenue / Employee
614.90K CHF
Profits / Employee
91.32K CHF
Market Cap
231.65B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 103,249 | -356 | -0.34% |
| Dec 31, 2023 | 103,605 | -8 | -0.01% |
| Dec 31, 2022 | 103,613 | 2,693 | 2.67% |
| Dec 31, 2021 | 100,920 | -545 | -0.54% |
| Dec 31, 2020 | 101,465 | 3,730 | 3.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Novartis AG | 75,883 |
| Lonza Group AG | 18,944 |
| Galderma Group AG | 6,545 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Straumann Holding AG | 11,815 |
| Sonova Holding AG | 18,366 |
| Ypsomed Holding AG | 2,644 |
Roche Holding AG News
- 6 hours ago - Roche receives CE mark for Contivue, its Port Delivery Platform containing Susvimo, for neovascular age-related macular degeneration (nAMD) - GlobeNewsWire
- 18 hours ago - Global drugmakers rush to boost US presence as tariff threat looms - Reuters
- 4 days ago - Alnylam (ALNY) Advances with Roche on Phase 3 Cardiovascular Trial for Zilebesiran - GuruFocus
- 4 days ago - Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for ... - GuruFocus
- 4 days ago - Genentech and Alnylam Advance Zilebesiran Into Global Phase III Cardiovascular Outcomes Trial for People With Uncontrolled Hypertension - Business Wire
- 4 days ago - Roche and Alnylam advance zilebesiran into global phase III cardiovascular outcomes trial for people with uncontrolled hypertension - GlobeNewsWire
- 5 days ago - Analog Devices Chair & CEO Trades $5.09M In Company Stock - Benzinga
- 9 days ago - Roche's US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA - GlobeNewsWire